View drug registration information details.
| Items | Registration information |
|---|
| ID | 287 |
|---|
| No | 287 |
|---|
| Brand Name | DACOMAKS 15 |
|---|
| Ingredients | DACOMITINIB 15 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30"C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 30 TABLETS/BOTTLE |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | FOR FIRSTLINE TREATMENT OF PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETION OR EXON 21 L858R SUBSTITUTION MUTATION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | BLUE ROUND, FILM COATED TABLET |
|---|
| Note | |
|---|
| License Owner | FACTORY NO.2 |
|---|
| Manufacturer | FACTORY NO. 2 |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 L 1276/24 |
|---|
| FDD Registration Date | 2025-01-13 |
|---|
| Expiry Date | 2030-01-12 |
|---|
Back to drug list
|
